A new poll shows that Republican Rep. John Boozman has widened his lead over incumbent Democratic Sen. Blanche Lincoln in his bid to unseat her.
New treatments for addiction to heroin or narcotic painkillers promise longer-lasting relief that may remove some day-to-day uncertainty of care: A once-a-month shot is now approved and a six-month implant is in the final testing phase.
The Food and Drug Administration is considering new restrictions on widely used anemia drugs that appear to double the risk of stroke in patients with kidney disease.
Almost two years ago, the Food and Drug Administration ignored the advice of its scientists and approved a knee implant after being lobbied by members of Congress. On Thursday, the agency issued an unprecedented "mea culpa," saying the device should not have been approved.
The Food and Drug Administration warned eight companies on Thursday to stop marketing miracle cures that claim to treat everything from autism to Parkinson's disease by flushing toxic metals from the body.
The Food and Drug Administration issued an unprecedented "mea culpa" Thursday, saying it made a mistake in approving a knee implant against the advice of its scientific reviewers.
The U.S. Justice Department said Wednesday that FBI agents acted properly when they fatally shot a Detroit Muslim cleric who brandished a gun and fired at them as they tried to arrest him last year.
Government health officials warned doctors and patients Wednesday about an increased risk of thigh fractures with a widely used group of bone-strengthening drugs.
In a story Oct. 11, The Associated Press reported that the Food and Drug Administration denied approval to JZP-6, a Jazz Pharmaceuticals drug candidate intended to treat fibromyalgia. The drug is approved under the name Xyrem as a treatment for narcolepsy and cataplexy.